mRESVIA Dispersion for Injection in Pre-Filled Syringe 50mcg/0.5ml

ModernaTX, Inc. (manufacturer of LMX-100 and mRNA-1345 LNP) (UNITED STATES)Rovi Pharma Industrial Services, S.A. (Rovi JC) (SPAIN)🇸🇬 Health Sciences Authority

Approval Date: Mar 6, 2026
Approval ID: 08995ef101c324fa
Company: ModernaTX, Inc. (manufacturer of LMX-100 and mRNA-1345 LNP) (UNITED STATES)Rovi Pharma Industrial Services, S.A. (Rovi JC) (SPAIN)
Type: Therapeutic

Approval Details

Approval Id: 08995ef101c324fa
Drug Name: mRESVIA Dispersion for Injection in Pre-Filled Syringe 50mcg/0.5ml
Product Name: mRESVIA Dispersion for Injection in Pre-Filled Syringe 50mcg/0.5ml
Approval Number: SIN17482P
Approval Date: 2026-03-06
Registrant: MODERNA BIOTECH SINGAPORE PTE. LTD.
Drug Type: Therapeutic
Forensic Classification: Prescription Only
Dosage Form: INJECTION, SOLUTION
Route Of Administration: INTRAMUSCULAR

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Mar 6, 2026

Approval ID

08995ef101c324fa

Type

Therapeutic

Back to HSA Approvals